{"name":"VHsquared Ltd.","slug":"vhsquared-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNdmlUaGktZkFKbGhPQ2MyRmtlVDlxejg3SFc2M25EWXdaVVU4SVIxNy1GVFl6aVJ0VnFONEMtTWQwclBKdkVqNTBZN21RUTRXQUhLSW1YLThCNjlLTjJpbWtaZldlbjBjQmM1VW9HRmFoR2pXcU9Md1FDdmFZRm5MUjN0MjhMVzQtTlJrcEk5LXVXdkZvdVROcXBMWG5rQQ?oc=5","date":"2024-12-19","type":"trial","source":"endpoints.news","summary":"Exclusive: Can oral antibodies work? A small startup thinks it has an answer - endpoints.news","headline":"Exclusive: Can oral antibodies work? A small startup thinks it has an answer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxNMVBaRmxTUlZYYlVWSDVjcTktZFljZjFfcE9VbDlMR29mYUNmdGhENU1KMTRoVG1NcnVtUVphMnJuMXB0V0tCb1ZGVFZIOVFPMDBjQ3NNTC1ETWdnOFJGTy12Y2VJM1VLbDZzYlQ0bmlGRlhBb0Y0dlpPZ2hwb213TW01Z1RETzBBTU9vbFdtcjhaZHdMZERpbWlRQ0dCa2c1SVB2MXVkWjJrSXk5V0Z4Z1VneTlreEFEX0h2dW54NGpnRGt0a29fLW5xZEZoMDg4V0dDRGhvMDV1Q3hmQTlNcmJieVBmTEdoRXlvZ0hvcXdqbDdFazdMSGEwSU4yQkFGdVg4R1Nla3lXQ19hOUtwX0lJZVlBLTFVQkpF?oc=5","date":"2024-07-15","type":"regulatory","source":"PR Newswire","summary":"SKYRIZI's Approval For Ulcerative Colitis Treatment Expands AbbVie's Portfolio Across Immune-mediated Inflammatory Diseases | DelveInsight - PR Newswire","headline":"SKYRIZI's Approval For Ulcerative Colitis Treatment Expands AbbVie's Portfolio Across Immune-mediated Inflammatory Disea","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOcTVialNPQVZGYTRsU0duOFRGSHdQQmNFZ05pdkFjNE1rRnQ2d2VZaENiY2ZzYTQ3cUNWcExZMUdNeGNsQlNSN2FPUXIzX0Rob2w2ZHkwQUdhaUxhcmZwM0VXZ19XZGU3YXhQdFRoQ1NGRkVtSkhCV2hqZ2hzQzJMaUZoV1BIZmJpLXpNZWtUVFJ4QkRKWmVwbEZDRTRjSWlyVHlSazI1SjJXbzFWVVhlTTI5eXVvS1ZqeElhOEpkSUdZOFM4WVZTVmZkQQ?oc=5","date":"2022-11-23","type":"pipeline","source":"Healio","summary":"VEGA: Guselkumab plus golimumab achieved higher clinical remission rates in UC - Healio","headline":"VEGA: Guselkumab plus golimumab achieved higher clinical remission rates in UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNemRXMXdubFhLX2ktWlhUUEtMNzRaQVA3djVjbWhsSVV2RFlqT2pVUWtfZWVHRkQ1Q1JVNE1PWUJNUjY4cmg2czN6R0VabjIxZFF4RWxqeHFxeUpQYk5YcmlCQjg2cnZReDFia3pxVjIwY1pEakhEbW5oZDdQMmpfRExOWHFONDZhVDZsY3hZeGJRdmkzWnV0TmJwZ1VKVng1akpqMXRqWEVGdnV0dUE4dXpHX25WODN5YUl2YmRtcDlTOFNjbGRnQTN3cUFGM21jVmc?oc=5","date":"2022-10-24","type":"pipeline","source":"Healio","summary":"Higher-dose upadacitinib reduces disease severity, prolongs clinical remission in UC - Healio","headline":"Higher-dose upadacitinib reduces disease severity, prolongs clinical remission in UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNRjFqRFFFZWM3bWtjRngyRDQ5dXlJSnN4UTZoMzBnVk5Vejl3VE1WUV9KMWNqcDJpSXFJWUZlaW5zb3Q5T0xvdW9aODhLeGk5eDZ0ck1haVM5bmw5R0FCVmFrWThUTnpaTXdPTW5aX3VDX0sxbWZ3TGNHMzdlUGZpa21ERHJQcFA1UU1NanRpUTJmZHBuVXRncndTOWFWZUZqWGFOQzFuMUxhU1IwN1IxV1V3bWZmVjJtUnhWVFZMQzN5NXNrSW5nWFloWW1RdkxqU0tGQTgwQ3owcE9HZnlOQVoyODdiUnlMT1BxNg?oc=5","date":"2018-08-28","type":"pipeline","source":"European Medical Journal","summary":"Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future - European Medical Journal","headline":"Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNZVZrUFo5eU1QWFJMaXl6b0lyeHR5U1VEdHdhSkNmbmJZdFRLdC1PWTRTdWRoVmEtV3oyOF9ZM3dKbFVBdHpmZUJEMHBQNU1YU1dJOE9QMkFzOVppVG4tZE1jY3NsX203VXFmbGtZMUFwbzJFelhmYmJ6bXZUNldZTDhJbDVQNzZMbXlNNDMwMDRveTZUQWd4QTdVbGhyd2FWUjdNVXR6ZUczX0ZObHlvRFBYSHRYLWVUd1BNdE1nLTh6ZjJiazZDQ1Jn?oc=5","date":"2017-05-16","type":"pipeline","source":"European Medical Journal","summary":"Changing the Game in Ulcerative Colitis: The Impact of Gut-Selective Therapy - European Medical Journal","headline":"Changing the Game in Ulcerative Colitis: The Impact of Gut-Selective Therapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}